This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, with a ceiling value of $1,056.50, is for the delivery of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of November 14, 2024.
Dakota Drug, Inc. is the prime contractor for this award, which is not set aside. The company holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the ECAT Generation V Program. This IDC enables Dakota Drug, Inc. to efficiently deliver a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations.
Generated 2/12/25, 9:33 AM